Odyssey Health (ODYY) R&D In Process (2021 - 2023)
Odyssey Health's quarterly R&D In Process came in at $170000.0 in Q1 2023, down 98.2% quarter-over-quarter from $9.4 million in Q2 2021.
Odyssey Health has reported R&D In Process for 2 years, with the latest figure at $170000.0 in Q1 2023.
- For the quarter ending Q1 2023, R&D In Process changed N/A year-over-year to $170000.0; the trailing twelve-month figure through Jan 2023 stood at $170000.0 (down 98.2% YoY), and the FY2021 full-year result was $9.4 million, changed N/A from the prior year.
- R&D In Process for Q1 2023 stood at $170000.0, down from $9.4 million in the prior quarter.
- The five-year high for R&D In Process was $9.4 million in Q2 2021, with the low at $170000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D In Process (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2023 | 170,000.00 |
| Apr 30, 2021 | 9.44 Mn |